Product NDC: | 0228-3262 |
Proprietary Name: | Oxymorphone hydrochloride |
Non Proprietary Name: | Oxymorphone hydrochloride |
Active Ingredient(s): | 15 mg/1 & nbsp; Oxymorphone hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0228-3262 |
Labeler Name: | Actavis Elizabeth LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079046 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101231 |
Package NDC: | 0228-3262-11 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-3262-11) |
NDC Code | 0228-3262-11 |
Proprietary Name | Oxymorphone hydrochloride |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-3262-11) |
Product NDC | 0228-3262 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxymorphone hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101231 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Elizabeth LLC |
Substance Name | OXYMORPHONE HYDROCHLORIDE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |